|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment显示文摘 | Thomas Aparicio Aziz Zaanan Magali Svrcek Pierre Laurent-Puig Nicolas Carrere Sylvain Manfredi Christophe Locher Pauline Afchain | 2014 | Digestive and Liver Disease2014，，2： | 3 |
| 2 | Gender differences in the response of colitis to smoking显示文摘 | Jacques Cosnes Isabelle Nion-larmurier Pauline Afchain Laurent Beaugerie Jean-pierre Gendre | 2004 | Clinical Gastroenterology and Hepatology2004，，： | 2 |
| 3 | Concomitant administration of weekly oxaliplatin,fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a groupe coordinateur multidisciplinaire en oncologie phase ii study 显示文摘 | Moureau-Zabotto L Philip JM Afchain P | 2008 | J Clin Oncol2008，26，7： | 1 |
| 4 | Adjuvant treatment of colorectalcancer显示文摘 | Sequra C Afchain P de Gramont A | 2006 | Bull Cancer2006，93，7： | 1 |
| 5 | Concomitant ad-ministration of weekly oxaliplatin, fluorouracil continuous infusion,and radiotherapy after 2 months of gemcitabine and oxaliplatin in-duction in patients with locally advanced pancreatic cancer : a groupcoordinateur multidisciplinaire en oncologie phase D study 显示文摘 | Moureau -Zabotto L Philip JM Afchain P | 2008 | JClin Oncol2008，26，7： | 1 |
| 6 | Impact of Preoperative and Postoperative FOLFOX Chemotherapies in Patients with Resectable Colorectal Liver Metastasis显示文摘 | Matthieu Faron Mircea Chirica Hadrien Tranchard Pierre Balladur Aimery Gramont Pauline Afchain Thierry Andre Fran?ois Paye | 2014 | Journal of Gastrointestinal Cancer2014，，3： | 1 |
| 7 | Serodiagnosis of Toxoplasma infection using a purified parasite protein (P30)显示文摘 | SANTORO F AFCHAIN D PIERCE R | 1985 | Clin Exp Immunol1985，62，2： | 1 |
| 8 | Efficacy of irino- tecan in combination with 5-fluorouracil (FOLFIRI) for me- tastatic gastric or gastroesophageal junction adenoearcinomas (MGA) treatment 显示文摘 | Samalin E Afchain P Thzenas S | 2011 | Clin Res Hepatol Gastroenterol2011，35，1： | 1 |
| 9 | Seroduagnosis of toxoplasma infection using a purified parasite protein (p30) 显示文摘 | Santoro F Afchain D pierce R et a1 | 1985 | Clin Exp Immunol1985，62，2： | 1 |
| 10 | Concomitant ad- ministration of weekly oxaliplatin, fluorouracil continuous infu- sion, and radiotherapy after 2 months of gemcitabine and oxalipla- tin induction in patients with locally advanced pancreatic eaneer:a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study 显示文摘 | Moureau - Zabotto L Phrlip JM Afchain P | 2008 | J Clin Onco12008，26，7： | 1 |
| 11 | Chemotherapy in gallbladder carcinoma显示文摘 | Abahssain H Afchain P Melas N | 2010 | Presse Med2010，39，12： | 1 |
| 12 | Serodiagnosis of Toxoplasma in- fection using a purified parasite protein (P30) 显示文摘 | Santoro F Afchain D Pierce R | 1985 | Clin Exp Immunol1985，62，2： | 1 |
| 13 | Serodiagnosis of Toxoplasma infection using a purified parasite protein (P30) 显示文摘 | Santoro F Afchain D Pierce R | 1985 | Clin Exp Immunol1985，62，2： | 1 |
| 14 | Major surface protein of Toxoplasma gondii (P30) contains an immunodominant region with repetitive epitopes 显示文摘 | Rodriguez C Afchain D Capron A | 1985 | Eur J Immunol1985，15，7： | 1 |
| 15 | serodianosis of toxoplasma infection using a purified parasite protein(P30)显示文摘 | Santoro F Afchain D Pierce R | 1985 | Clin Exp Immunol1985，62，2： | 1 |
| 16 | 克罗恩病合并肠穿孔:外科切除的预测性因素显示文摘New medical therapeutic options challenge the usual surgical management of Crohn’ s disease patients with intestinal perforation. Objectives-To determine factors predictive of surgery for perforation in Crohn’ s disease and define a group of patients that may benefit from non-surgical treatment. Methods-One hundred and sixty-two patients (69 males, 93 females, mean age 39) with perforated Crohn’ s disease (fistula, abscess, inflammatory mass) between January 1995 and September 2003 were studied retrospectively. Results-One hundred and fifty-one patients (93% ) underwent surgery: 70 had planned surgery and 81 had surgery for symptomatic deterioration. At two years, the cumulative probability of intestinal resection was 0.89 ≥ 0.03, and the cumulative probability of unplanned intestinal resection was 0.72 ≥ 0.05. Predictive factors of unplanned surgery were elevated platelet count (adjusted hazard ratio 3.15; 95% CI 2.21-4.50) and absence of fistula (adjusted hazard ratio 3.14; 95% CI 2.48-3.99). The rate of postoperative complications, the need for a stoma, and the length of bowel resection were not significantly different whether the surgery was planned or not. Conclusion-A significant proportion of patients with intestinal perforation complicating Crohn’ s disease, particularly those with a fistula, might benefit from non-surgical treatment. | Brihier H. Nion-Larmurier I. Afchain P. J. Cosnes 张欣 | 2006 | 世界核心医学期刊文摘(胃肠病学分册)2006，2，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员